Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 18 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(41.7%)
Phase 2
3(25.0%)
Phase 1
2(16.7%)
Phase 3
1(8.3%)
Phase 4
1(8.3%)
12Total
N/A(5)
Phase 2(3)
Phase 1(2)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT06868004Not ApplicableCompleted

Holistic Nursing Benefits Cognitive and Psychiatric Symptoms in Alzheimer's Patients

Role: lead

NCT04735861Phase 2Completed

Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma

Role: collaborator

NCT06345365Phase 3Recruiting

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Role: collaborator

NCT05794425Phase 1Recruiting

Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders

Role: collaborator

NCT05092178Not ApplicableCompleted

Calorie Restricted Diet and Exercise

Role: lead

NCT05114694Not ApplicableUnknown

Early Arthroscopic Partial Meniscectomy(APM)

Role: lead

NCT03662633Unknown

Diagnosis Value of SEMA4C in Breast Cancer

Role: collaborator

NCT05205187Unknown

Gut Microbiota and Metabonomics

Role: collaborator

NCT03663153Not Yet Recruiting

SEMA4C as a Relapse Biomarker in Breast Cancer

Role: collaborator

NCT04214782Not ApplicableUnknown

Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm

Role: collaborator

NCT03193879Completed

Effects of Particulate Matter on the Pulmonary Function and Acute Exacerbation of COPD and Asthma

Role: collaborator

NCT04921202Completed

Metabolic Syndrome and Degenerative Meniscus Lesions Related Knee Function

Role: lead

NCT04837456Not ApplicableCompleted

Metabolic Syndrome and Degenerate Meniscus Tears

Role: lead

NCT04612673Phase 2Unknown

A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC

Role: collaborator

NCT04008511Phase 1Unknown

Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer

Role: collaborator

NCT03178136Unknown

HR-HPV Multi-site Opportunistic Screening in Liaoning, China

Role: collaborator

NCT03732001Phase 2Unknown

A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLC

Role: collaborator

NCT02999048Phase 4Completed

Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin

Role: lead

All 18 trials loaded